Source comparison
Receptor Pathway Differences: GHRH vs Ghrelin Mimetics
CJC-1295 binds to growth hormone-releasing hormone receptors (GHRH-R) on somatotroph cells in the anterior pituitary. The same receptor pathway activated by endogenous GHRH secreted from the hypothalamus. The DAC modification (a synthetic peptide sequence that
This comparison does not assign a generated winner or score.
- CJC-1295 binds to growth hormone-releasing hormone receptors (GHRH-R) on somatotroph cells in the anterior pituitary. The same receptor pathway activated by endogenous GHRH secreted from the hypothalamus. The DAC modification (a synthetic peptide sequence that binds non-covalently to serum albumin) extends the molecule's circulation time from 30 minutes (non-DAC GHRH analogs) to 6–8 days, creating sustained receptor occupancy that elevates baseline GH secretion without requiring pulsatile administration. Research from the University of Virginia published in 2006 demonstrated that a single 30mcg/kg dose of CJC-1295 elevated mean 24-hour GH levels by 200–300% for up to 13 days post-injection.
- Ipamorelin operates through the ghrelin receptor (growth hormone secretagogue receptor type 1a, or GHSR-1a), a completely separate pathway from GHRH signaling. Ghrelin is the endogenous 'hunger hormone' that also triggers acute GH pulses in response to fasting or caloric deficit. Ipamorelin mimics this pathway without activating appetite signaling or elevating cortisol and prolactin (a known side effect of earlier secretagogues like GHRP-6). The plasma half-life is approximately 2 hours, meaning each dose produces a discrete secretory pulse that peaks within 30–45 minutes and returns to baseline within 3–4 hours. This pulsatile pattern more closely mimics natural GH secretion, which occurs in 6–8 discrete pulses over 24 hours rather than continuous elevation.
- The mechanistic consequence: CJC-1295 creates a sustained 'floor' elevation of GH, useful in models studying chronic IGF-1 upregulation or tissue anabolism over weeks. Ipamorelin produces acute 'ceiling' pulses, ideal for studying immediate post-secretion metabolic effects or receptor sensitivity without chronically suppressing endogenous GHRH production. Most contemporary research protocols layer both. CJC-1295 for baseline elevation, ipamorelin for superimposed pulses. To simulate supra-physiological GH profiles without the receptor downregulation seen with exogenous recombinant GH administration.